VTVT Shares Outstanding History



Below is a table of the VTVT shares outstanding history going back to 7/30/2015:

Date VTVT Shares Outstanding
7/30/2015195312
9/14/2015228917
11/11/2015228917
3/4/2016231866
5/13/2016241560
8/2/2016242259
11/3/2016242331
2/24/2017242331
5/3/2017242331
8/2/2017242331
11/1/2017242331
2/23/2018242331
5/15/2018243249
8/3/2018286057
11/8/2018441304
2/26/2019569818
5/1/2019681399
7/31/2019775973
8/13/20191.10M
10/30/2019920223
2/20/20201.05M
5/5/20201.12M
8/3/20201.20M
11/5/20201.27M
2/24/20211.44M
5/5/20211.45M
8/4/20211.50M
11/9/20211.67M
3/29/20221.67M
5/12/20221.67M
11/10/20222.04M
5/11/20232.04M
8/11/20232.04M
11/9/20232.04M
5/9/20242.43M
8/8/20242.43M
11/12/20242.61M
3/20/20252.61M
5/15/20252.62M
8/12/20252.62M

Also see: VTVT Market Cap History
VTVT YTD Return
VTVT Historical Shares Outstanding:
+29.48% CAGR
VTVT Historical Shares Outstanding: +29.48% CAGR

Mouse over chart for data details
7/30/2015 ...8/12/2025
vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases. Its products pipeline includes TTP399, TTP273, HPP737 and HPP593. TTP399 is an orally administered, small molecule, liver-selective glucokinase activator (GKA) in development potential oral anti-diabetic for the treatment of type I diabetes. TTP399 completed the SimpliciT-I Study, a Phase II trial in patients with type I diabetes as an add-on to insulin therapy. Its HPP737 is an orally administered, non-central nervous system (CNS) penetrant phosphodiesterase type 4 (PDE4) inhibitor that addresses inflammatory diseases. We show 40 historical shares outstanding datapoints in our coverage of VTVT's shares outstanding history.

Understanding the changing numbers of VTVT shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like VTVT versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching VTVT by allowing them to research VTVT shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree VTVT Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
vTv Therapeutics (VTVT) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

VTYX Shares Outstanding History
VVOS Shares Outstanding History
VVUS Shares Outstanding History
VXRT Shares Outstanding History
VYGR Shares Outstanding History
VYNE Shares Outstanding History
VYNT Shares Outstanding History
WAT Shares Outstanding History
WCG Shares Outstanding History
WGS Shares Outstanding History
More Healthcare companies »

 

VTVT Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2025, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 7.6%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 7.6%.